Brief: G1 Therapeutics And Pepper Bio Announce Global License Agreement For Lerociclib

G1 Therapeutics

01/05/2024 11:27

May 1 (Reuters) - G1 Therapeutics Inc  GTHX.O :
    * G1 THERAPEUTICS AND PEPPER BIO ANNOUNCE GLOBAL (EXCLUDING
ASIA-PAC) LICENSE AGREEMENT FOR LEROCICLIB
    * G1 THERAPEUTICS INC: EXPECTED TO RECEIVE UPFRONT PAYMENTS
TOTALING MID-SINGLE-DIGIT MILLIONS WITHIN 12 MONTHS
    * G1 THERAPEUTICS INC: ELIGIBLE TO RECEIVE A MAXIMUM OF
$135M UPON
ACHIEVEMENT OF DEVELOPMENT AND COMMERCIAL MILESTONES IN UP TO
THREE INDICATIONS
    * G1 THERAPEUTICS INC: PEPPER BIO WILL PAY G1 A DOUBLE-DIGIT
ROYALTY ON AGGREGATE ANNUAL NET SALES OF LEROCICLIB

Source text for Eikon:  ID:nGNXC3fQ5 
Further company coverage:  GTHX.O 

 (Reuters.Briefs@thomsonreuters.com)